Anomer Bio is a startup based in the United Kingdom, most recent round Pre-Seed, 1 tracked investor.
Anomer Bio is a company headquartered in the United Kingdom. Its most recent tracked round is Pre-Seed. Brouky records 1 investor associated with the company.
Anomer Bio is a London-based biotech startup focused on advancing glycoscience by developing synthetic monosaccharides aimed at enhancing immune responses and addressing complex health challenges. The company utilizes a proprietary platform that integrates multi-omics data, Nobel Prize-winning research tools, and clinical trial insights to design synthetic sugar therapeutics targeting glycans directly, with applications in immune and fibrotic diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.